Fratiglioni, L.

dementia phase disease trial alzheimer protein inhibitor effect development research study amyloid treatment factor therapy prevalence fondation mederic alzheimer phase iii study 2011– vol strategy immunotherapy receptor antibody people bene fits peptide bene fit center target fondation immunization university onset identi fied mederic oligomer author winblad b ab deposition inhibitor phase iii trials ab protein lancet fi nancial relationships deposition neurimmune therapeutics ag world diagnosis modulator g-secretase patient neurology aggregation group immunization trials identi immunization strategies amyloid pathway 2040 prevalence delay mechanism diagnose region future dementia prevalence g-secretase inhibitor population function brodaty interest growth alzheimer disease research centre nerve abeta vaccine research council 2011– health drug development progression